{"id":"https://openalex.org/W2534575348","doi":"https://doi.org/10.1021/acs.jmedchem.6b01385","title":"Development of Allosteric Hydrazide-Containing Class I Histone Deacetylase Inhibitors for Use in Acute Myeloid Leukemia","display_name":"Development of Allosteric Hydrazide-Containing Class I Histone Deacetylase Inhibitors for Use in Acute Myeloid Leukemia","alternate_titles":[],"publication_year":2016,"publication_date":"2016-10-18","ids":{"openalex":"https://openalex.org/W2534575348","doi":"https://doi.org/10.1021/acs.jmedchem.6b01385","mag":"2534575348","pmid":"https://pubmed.ncbi.nlm.nih.gov/27754681","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5260863"},"language":"en","primary_location":{"id":"doi:10.1021/acs.jmedchem.6b01385","doi":"https://doi.org/10.1021/acs.jmedchem.6b01385","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.6b01385","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2534575348"],"child_works_count":2,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5260863","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032440774","display_name":"Jesse J. McClure","orcid":"https://orcid.org/0000-0002-5689-4731","observed_orcids":["https://orcid.org/0000-0002-5689-4731"]},"institutions":[{"id":"https://openalex.org/I153297377","display_name":"Medical University of South Carolina","ror":"https://ror.org/012jban78","country_code":"US","type":"education","lineage":["https://openalex.org/I153297377"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jesse J. McClure","raw_affiliation_strings":["Department of Drug Discovery\rand Biomedical Sciences, South Carolina College of Pharmacy, Medical University of South Carolina, Charleston, South Carolina, 280 Calhoun Stret, MSC140 QF307, 29425, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Discovery\rand Biomedical Sciences, South Carolina College of Pharmacy, Medical University of South Carolina, Charleston, South Carolina, 280 Calhoun Stret, MSC140 QF307, 29425, United States","institution_ids":["https://openalex.org/I153297377"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100439667","display_name":"Cheng Zhang","orcid":"https://orcid.org/0000-0002-8760-8152","observed_orcids":["https://orcid.org/0000-0002-8760-8152"]},"institutions":[{"id":"https://openalex.org/I153297377","display_name":"Medical University of South Carolina","ror":"https://ror.org/012jban78","country_code":"US","type":"education","lineage":["https://openalex.org/I153297377"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cheng Zhang","raw_affiliation_strings":["Department of Drug Discovery\rand Biomedical Sciences, South Carolina College of Pharmacy, Medical University of South Carolina, Charleston, South Carolina, 280 Calhoun Stret, MSC140 QF307, 29425, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Discovery\rand Biomedical Sciences, South Carolina College of Pharmacy, Medical University of South Carolina, Charleston, South Carolina, 280 Calhoun Stret, MSC140 QF307, 29425, United States","institution_ids":["https://openalex.org/I153297377"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052118325","display_name":"Elizabeth S. Inks","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I153297377","display_name":"Medical University of South Carolina","ror":"https://ror.org/012jban78","country_code":"US","type":"education","lineage":["https://openalex.org/I153297377"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth S. Inks","raw_affiliation_strings":["Department of Drug Discovery\rand Biomedical Sciences, South Carolina College of Pharmacy, Medical University of South Carolina, Charleston, South Carolina, 280 Calhoun Stret, MSC140 QF307, 29425, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Discovery\rand Biomedical Sciences, South Carolina College of Pharmacy, Medical University of South Carolina, Charleston, South Carolina, 280 Calhoun Stret, MSC140 QF307, 29425, United States","institution_ids":["https://openalex.org/I153297377"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079214922","display_name":"Yuri K. Peterson","orcid":"https://orcid.org/0000-0002-4005-9678","observed_orcids":["https://orcid.org/0000-0002-4005-9678"]},"institutions":[{"id":"https://openalex.org/I153297377","display_name":"Medical University of South Carolina","ror":"https://ror.org/012jban78","country_code":"US","type":"education","lineage":["https://openalex.org/I153297377"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yuri K. Peterson","raw_affiliation_strings":["Department of Drug Discovery\rand Biomedical Sciences, South Carolina College of Pharmacy, Medical University of South Carolina, Charleston, South Carolina, 280 Calhoun Stret, MSC140 QF307, 29425, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Discovery\rand Biomedical Sciences, South Carolina College of Pharmacy, Medical University of South Carolina, Charleston, South Carolina, 280 Calhoun Stret, MSC140 QF307, 29425, United States","institution_ids":["https://openalex.org/I153297377"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100404202","display_name":"Jiaying Li","orcid":"https://orcid.org/0000-0001-7508-1579","observed_orcids":["https://orcid.org/0000-0001-7508-1579","https://orcid.org/0009-0000-1399-9878","https://orcid.org/0009-0002-2191-6221"]},"institutions":[{"id":"https://openalex.org/I153297377","display_name":"Medical University of South Carolina","ror":"https://ror.org/012jban78","country_code":"US","type":"education","lineage":["https://openalex.org/I153297377"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jiaying Li","raw_affiliation_strings":["Department of Drug Discovery\rand Biomedical Sciences, South Carolina College of Pharmacy, Medical University of South Carolina, Charleston, South Carolina, 280 Calhoun Stret, MSC140 QF307, 29425, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Discovery\rand Biomedical Sciences, South Carolina College of Pharmacy, Medical University of South Carolina, Charleston, South Carolina, 280 Calhoun Stret, MSC140 QF307, 29425, United States","institution_ids":["https://openalex.org/I153297377"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055213568","display_name":"C. James Chou","orcid":"https://orcid.org/0000-0001-6808-9089","observed_orcids":["https://orcid.org/0000-0001-6808-9089"]},"institutions":[{"id":"https://openalex.org/I153297377","display_name":"Medical University of South Carolina","ror":"https://ror.org/012jban78","country_code":"US","type":"education","lineage":["https://openalex.org/I153297377"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"C. James Chou","raw_affiliation_strings":["Department of Drug Discovery\rand Biomedical Sciences, South Carolina College of Pharmacy, Medical University of South Carolina, Charleston, South Carolina, 280 Calhoun Stret, MSC140 QF307, 29425, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Discovery\rand Biomedical Sciences, South Carolina College of Pharmacy, Medical University of South Carolina, Charleston, South Carolina, 280 Calhoun Stret, MSC140 QF307, 29425, United States","institution_ids":["https://openalex.org/I153297377"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5055213568"],"corresponding_institution_ids":["https://openalex.org/I153297377"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":1.7495,"has_fulltext":false,"cited_by_count":113,"citation_normalized_percentile":{"value":0.84146977,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"59","issue":"21","first_page":"9942","last_page":"9959"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.9269999861717224},{"id":"https://openalex.org/keywords/class-i-hdacs","display_name":"class I HDACs","score":0.8579999804496765},{"id":"https://openalex.org/keywords/allosteric-inhibition","display_name":"allosteric inhibition","score":0.9649999737739563},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9869999885559082},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.6230000257492065},{"id":"https://openalex.org/keywords/inhibitor-selectivity","display_name":"inhibitor selectivity","score":0.5889999866485596},{"id":"https://openalex.org/keywords/anticancer-drug-design","display_name":"anticancer drug design","score":0.5979999899864197}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8371233344078064},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.7014681100845337},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.607482373714447},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5388102531433105},{"id":"https://openalex.org/C2776281265","wikidata":"https://www.wikidata.org/wiki/Q420327","display_name":"Hydroxamic acid","level":2,"score":0.5175118446350098},{"id":"https://openalex.org/C166342909","wikidata":"https://www.wikidata.org/wiki/Q845326","display_name":"Allosteric regulation","level":3,"score":0.5132434368133545},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5010714530944824},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.4438607692718506},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.44006597995758057},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.43974852561950684},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.30241847038269043},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.26464372873306274},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.18235570192337036},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.1386769413948059},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.08984482288360596},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.08875137567520142},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08651655912399292},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000494","descriptor_name":"Allosteric Regulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006367","descriptor_name":"HeLa Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006655","descriptor_name":"Histone Deacetylases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006835","descriptor_name":"Hydrazones","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D006835","descriptor_name":"Hydrazones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006835","descriptor_name":"Hydrazones","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D007963","descriptor_name":"Leukocytes, Mononuclear","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D057809","descriptor_name":"HEK293 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1021/acs.jmedchem.6b01385","doi":"https://doi.org/10.1021/acs.jmedchem.6b01385","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.6b01385","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:27754681","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27754681","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:4593589","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5260863","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5260863","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5260863/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"J Med Chem","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:4593589","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5260863","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8048999905586243}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1243618768","display_name":"South Carolina Clinical & Translational Research Institute (SCTR)","funder_award_id":"UL1RR029882","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G3843897372","display_name":null,"funder_award_id":"UL1 RR029882","funder_id":"https://openalex.org/F4320333850","funder_display_name":"South Carolina Clinical and Translational Research Institute, Medical University of South Carolina"},{"id":"https://openalex.org/G6248903108","display_name":"Training To Improve Cardiovascular Therapies","funder_award_id":"T32HL007260","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G7908491126","display_name":"South Carolina COBRE in Oxidants, Redox Balance and Stress Signaling","funder_award_id":"P20GM103542","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G967614162","display_name":"Novel lysine deacetylase 6 Hsp domain inhibitors against AML","funder_award_id":"R01CA163452","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332464","display_name":"Hollings Cancer Center, Medical University of South Carolina","ror":"https://ror.org/00w52vt71"},{"id":"https://openalex.org/F4320333850","display_name":"South Carolina Clinical and Translational Research Institute, Medical University of South Carolina","ror":null},{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"},{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":53,"referenced_works":["https://openalex.org/W19734691","https://openalex.org/W1517396147","https://openalex.org/W1756696014","https://openalex.org/W1975144326","https://openalex.org/W1977454730","https://openalex.org/W1979832500","https://openalex.org/W1993510744","https://openalex.org/W2004800182","https://openalex.org/W2006978594","https://openalex.org/W2010437021","https://openalex.org/W2018613239","https://openalex.org/W2029820254","https://openalex.org/W2030145184","https://openalex.org/W2031954417","https://openalex.org/W2033747485","https://openalex.org/W2045856275","https://openalex.org/W2046345187","https://openalex.org/W2051985758","https://openalex.org/W2053504914","https://openalex.org/W2054433610","https://openalex.org/W2063819389","https://openalex.org/W2071115015","https://openalex.org/W2074669585","https://openalex.org/W2076869527","https://openalex.org/W2084849455","https://openalex.org/W2089122153","https://openalex.org/W2110192861","https://openalex.org/W2110957729","https://openalex.org/W2112351720","https://openalex.org/W2114138025","https://openalex.org/W2119478924","https://openalex.org/W2128566672","https://openalex.org/W2134459196","https://openalex.org/W2141920998","https://openalex.org/W2142946517","https://openalex.org/W2144109917","https://openalex.org/W2157888813","https://openalex.org/W2160460552","https://openalex.org/W2160614740","https://openalex.org/W2165392081","https://openalex.org/W2167118090","https://openalex.org/W2169724454","https://openalex.org/W2179490146","https://openalex.org/W2298333171","https://openalex.org/W2318951702","https://openalex.org/W2389348607","https://openalex.org/W2404665693","https://openalex.org/W2418363598","https://openalex.org/W2465101233","https://openalex.org/W2467200112","https://openalex.org/W2468556268","https://openalex.org/W2470764319","https://openalex.org/W2473894594"],"related_works":["https://openalex.org/W4402604859","https://openalex.org/W4200185105","https://openalex.org/W2055582346","https://openalex.org/W4200383810","https://openalex.org/W26949131","https://openalex.org/W2179342674","https://openalex.org/W4229019496","https://openalex.org/W2044878334","https://openalex.org/W2901762139","https://openalex.org/W2152831388"],"abstract_inverted_index":{"One":[0],"of":[1,13,34,62,67,77,105,123],"the":[2,10,24,60],"biggest":[3],"hurdles":[4],"yet":[5],"to":[6,23,40,55,93],"be":[7],"overcome":[8],"for":[9,135],"continued":[11],"improvement":[12],"histone":[14],"deacetylase":[15],"(HDAC)":[16],"inhibitors":[17,69,84,90],"is":[18,37],"finding":[19],"alternative":[20],"motifs":[21],"equipotent":[22],"classic":[25],"and":[26,79,95,101,111,128],"ubiquitously":[27],"used":[28],"hydroxamic":[29],"acid.":[30],"The":[31],"N-hydroxyl":[32],"group":[33],"this":[35,47,71],"motif":[36,48],"highly":[38],"subject":[39],"sulfation/glucoronidation-based":[41],"inactivation":[42],"in":[43,53],"humans;":[44],"compounds":[45],"containing":[46],"require":[49],"much":[50],"higher":[51],"dosing":[52],"clinic":[54],"achieve":[56],"therapeutic":[57],"concentrations.":[58],"With":[59],"goal":[61],"developing":[63],"a":[64,75,86],"second":[65],"generation":[66],"HDAC":[68,83],"lacking":[70],"hydroxamate,":[72],"we":[73],"designed":[74],"series":[76],"potent":[78],"selective":[80,134],"class":[81],"I":[82],"using":[85],"hydrazide":[87],"motif.":[88],"These":[89],"are":[91,129],"impervious":[92],"glucuronidation":[94],"demonstrate":[96,114],"allosteric":[97],"inhibition.":[98],"In":[99],"vitro":[100],"ex":[102],"vivo":[103],"characterization":[104],"our":[106],"lead":[107],"analogues'":[108],"efficacy,":[109],"selectivity,":[110],"toxicity":[112],"profiles":[113],"that":[115],"they":[116],"possess":[117],"low":[118],"nanomolar":[119],"activity":[120],"against":[121],"models":[122],"acute":[124],"myeloid":[125],"leukemia":[126],"(AML)":[127],"at":[130],"least":[131],"100-fold":[132],"more":[133],"AML":[136],"than":[137],"solid":[138],"immortalized":[139],"cells":[140],"such":[141],"as":[142],"HEK293":[143],"or":[144],"human":[145],"peripheral":[146],"blood":[147],"mononuclear":[148],"cells.":[149]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2534575348","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":16},{"year":2024,"cited_by_count":20},{"year":2023,"cited_by_count":21},{"year":2022,"cited_by_count":13},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":3}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-10-28T00:00:00"}
